bf/NASDAQ:ASND_icon.jpeg

COM:ASCENDISPHARMA

Ascendis Pharma

  • Stock

USD

Last Close

122.64

22/11 21:00

Market Cap

7.78B

Beta: -

Volume Today

378.33K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
37.70M
-
103.04M
173.29%
169.80M
64.79%
average payables
2.53M
-
3.74M
47.98%
6.66M
78.29%
10.73M
60.93%
18.42M
71.77%
21.75M
18.08%
23.75M
9.19%
24.83M
4.54%
40.66M
63.73%
80.22M
97.32%
97.80M
21.91%
average receivables
3.89M
-
2.04M
47.53%
2.28M
11.79%
1.93M
15.52%
2.02M
4.93%
2.50M
23.82%
4.02M
60.67%
6.38M
58.61%
15.27M
139.32%
24.41M
59.88%
40.70M
66.76%
book value per share
0.58
-
2.70
363.71%
5.06
87.17%
6.65
31.32%
5.57
16.26%
6.82
22.43%
12.84
88.36%
16.57
29.06%
16.13
2.64%
4.70
70.89%
-2.59
155.11%
capex per share
-0.11
-
-0.02
78.38%
-0.04
82.81%
-0.03
42.13%
-0.03
10.62%
-0.06
130.31%
-0.11
72.11%
-0.43
283.84%
-0.44
3.91%
-0.26
41.60%
-0.04
83.21%
capex to depreciation
-2.95
-
-0.80
72.77%
-1.86
131.72%
-0.99
46.69%
-1.28
29.16%
-3.01
134.72%
-0.77
74.37%
-2.28
195.76%
-1.57
30.97%
-0.81
48.76%
-0.13
84.00%
capex to operating cash flow
-0.19
-
0.02
111.62%
0.02
8.62%
0.01
53.28%
0.01
11.39%
0.02
92.80%
0.03
53.71%
0.08
170.66%
0.06
26.89%
0.03
49.63%
0.01
82.12%
capex to revenue
-0.06
-
-0.03
50.54%
-0.13
341.89%
-0.15
13.99%
-0.62
321.55%
-0.25
59.31%
-0.39
54.13%
-3.10
703.61%
-3.12
0.52%
-0.28
90.91%
-0.01
96.77%
cash per share
1.80
-
2.96
64.68%
5.03
69.95%
6.79
34.84%
5.81
14.42%
6.76
16.41%
12.86
90.16%
14.20
10.42%
12.45
12.31%
13.12
5.33%
7.10
45.90%
days of inventory on hand
7.81K
-
3.93K
49.70%
1.72K
56.29%
days payables outstanding
6.16K
-
3.04K
50.64%
777.49
74.41%
days sales outstanding
30.49
-
61.99
103.30%
98.29
58.54%
132.10
34.40%
566.82
329.09%
90.72
83.99%
147.72
62.82%
385.53
160.99%
1.09K
182.23%
182.78
83.20%
76.32
58.24%
debt to assets
0.05
-
0.09
73.48%
0.10
3.06%
0.47
382.21%
0.78
67.28%
debt to equity
0.06
-
0.11
78.82%
0.12
8.32%
1.93
1,525.18%
-4.42
329.06%
dividend yield
0.01
-
earnings yield
0.03
-
-0.04
232.42%
-0.08
125.09%
-0.13
63.99%
-0.11
17.43%
-0.06
47.99%
-0.04
34.77%
-0.06
60.01%
-0.06
2.39%
-0.09
54.24%
-0.08
17.43%
enterprise value
128.54M
-
214.40M
66.80%
281.02M
31.07%
328.09M
16.75%
918.28M
179.89%
1.97B
114.59%
5.21B
164.62%
6.44B
23.58%
6.17B
4.33%
6.48B
5.07%
6.66B
2.89%
enterprise value over ebitda
22.61
-
-18.67
182.55%
-6.81
63.51%
-4.55
33.22%
-8.36
83.70%
-13.12
57.02%
-24.03
83.11%
-19.59
18.45%
-14.55
25.73%
-12.28
15.59%
-15.21
23.82%
ev to operating cash flow
20.37
-
-11.65
157.19%
-6.47
44.51%
-5.45
15.68%
-9.66
77.12%
-14.20
47.03%
-29.64
108.76%
-23.73
19.93%
-14.76
37.80%
-13.07
11.48%
-14.26
9.13%
ev to sales
6.30
-
15.33
143.44%
34.62
125.77%
71.23
105.77%
600.19
742.60%
186.24
68.97%
389.86
109.34%
926.81
137.73%
792.62
14.48%
126.58
84.03%
24.99
80.26%
free cash flow per share
0.47
-
-1.11
334.53%
-1.87
68.62%
-2.29
22.33%
-2.86
24.68%
-3.44
20.54%
-3.89
13.10%
-5.79
48.71%
-8.07
39.32%
-9.10
12.78%
-8.35
8.27%
free cash flow yield
0.03
-
-0.07
305.65%
-0.11
56.25%
-0.12
7.75%
-0.09
27.95%
-0.06
27.05%
-0.03
50.16%
-0.04
34.77%
-0.07
60.73%
-0.08
17.12%
-0.07
7.90%
graham net net
0.03
-
2.31
7,948.61%
4.62
100.25%
6.33
36.94%
5.16
18.54%
5.86
13.74%
11.24
91.61%
11.52
2.55%
9.78
15.09%
-0.11
101.16%
-7.56
6,545.59%
graham number
2.23
-
5.89
164.63%
12.56
113.23%
19.64
56.36%
21.48
9.38%
22.04
2.58%
36.80
66.99%
55.55
50.95%
50.42
9.24%
33.15
34.25%
22.32
32.68%
income quality
1.55
-
1.91
23.18%
1.32
30.71%
0.88
33.46%
0.77
12.62%
1.07
39.00%
0.81
24.36%
0.65
19.68%
1.09
67.99%
0.85
21.94%
0.97
14.21%
intangibles to total assets
0.13
-
0.06
54.49%
0.03
55.48%
0.02
30.67%
0.02
9.91%
0.01
33.86%
0.01
52.87%
0.01
12.98%
0.00
16.72%
0.00
8.83%
0.01
20.81%
interest coverage
659.88
-
-749.31
213.55%
-6.97K
830.30%
-14.58K
109.21%
-1.15K
92.12%
-1.22K
5.97%
-185.68
84.76%
-172.38
7.17%
-115.52
32.99%
-11.13
90.37%
-10.34
7.10%
interest debt per share
0.00
-
0.00
27.56%
0.00
73.28%
0.00
25.44%
0.00
1,432.58%
0.00
7.16%
0.81
26,221.84%
1.85
127.99%
1.99
7.16%
9.97
401.42%
12.23
22.69%
inventory turnover
0.05
-
0.09
98.80%
0.21
128.77%
invested capital
0.06
-
0.11
78.82%
0.12
8.32%
1.93
1,525.18%
-4.42
329.06%
market cap
147.97M
-
264.57M
78.80%
400.67M
51.44%
508.41M
26.89%
1.11B
119.04%
2.25B
101.90%
5.78B
156.89%
6.94B
20.10%
6.51B
6.20%
6.41B
1.42%
6.41B
0.02%
net current asset value
800K
-
40.30M
4,937.63%
114.21M
183.39%
170.50M
49.29%
180.87M
6.08%
253.99M
40.43%
531.55M
109.28%
599.05M
12.70%
604.60M
0.93%
97.08M
83.94%
-268.56M
376.64%
net debt to ebitda
-3.42
-
4.37
227.78%
2.90
33.60%
2.50
13.79%
1.78
28.90%
1.85
4.07%
2.59
39.83%
1.50
42.11%
0.81
46.21%
-0.12
114.97%
-0.58
376.97%
net income per share
0.38
-
-0.57
251.02%
-1.39
142.90%
-2.58
86.17%
-3.68
42.88%
-3.17
14.06%
-4.69
48.04%
-8.28
76.56%
-7.00
15.39%
-10.40
48.52%
-8.55
17.76%
operating cash flow per share
0.58
-
-1.09
286.02%
-1.83
68.30%
-2.27
23.87%
-2.83
24.84%
-3.38
19.46%
-3.78
11.98%
-5.36
41.81%
-7.63
42.13%
-8.84
15.94%
-8.30
6.08%
payables turnover
0.06
-
0.12
102.61%
0.47
290.79%
receivables turnover
11.97
-
5.89
50.81%
3.71
36.92%
2.76
25.60%
0.64
76.69%
4.02
524.78%
2.47
38.58%
0.95
61.68%
0.34
64.57%
2.00
495.29%
4.78
139.47%
research and ddevelopement to revenue
0.62
-
1.41
126.14%
4.99
254.39%
14.33
187.12%
65.09
354.10%
13.26
79.63%
14.33
8.06%
37.52
161.91%
38.04
1.37%
7.42
80.50%
1.55
79.10%
return on tangible assets
0.18
-
-0.18
199.58%
-0.26
46.62%
-0.37
43.07%
-0.60
62.63%
-0.41
30.94%
-0.32
21.47%
-0.43
32.82%
-0.36
17.40%
-0.54
51.30%
-0.59
9.07%
revenue per share
1.89
-
0.83
56.30%
0.34
58.63%
0.17
49.24%
0.05
73.76%
0.26
466.02%
0.29
11.67%
0.14
52.24%
0.14
3.38%
0.91
542.68%
4.74
419.20%
roe
0.65
-
-0.21
132.57%
-0.27
29.77%
-0.39
41.77%
-0.66
70.62%
-0.46
29.81%
-0.37
21.40%
-0.50
36.81%
-0.43
13.10%
-2.21
410.16%
3.30
249.22%
roic
0.73
-
-0.24
133.66%
-0.34
39.43%
-0.41
20.74%
-0.59
44.23%
-0.55
7.17%
-0.34
38.68%
-0.32
4.36%
-0.41
27.74%
-0.73
78.02%
-0.77
5.38%
sales general and administrative to revenue
0.12
-
0.45
279.01%
1.16
158.48%
2.50
115.35%
8.81
252.81%
2.37
73.13%
3.62
53.04%
shareholders equity per share
0.58
-
2.70
363.71%
5.06
87.17%
6.65
31.32%
5.57
16.26%
6.82
22.43%
12.84
88.36%
16.57
29.06%
16.13
2.64%
4.70
70.89%
-2.59
155.11%
stock based compensation to revenue
0.03
-
0.09
177.11%
0.21
131.60%
1.59
653.25%
6.35
299.24%
1.86
70.73%
2.80
50.90%
7.65
172.85%
8.59
12.36%
1.25
85.40%
0.25
80.07%
tangible asset value
2.81M
-
42.31M
1,408.02%
116.83M
176.11%
173.12M
48.17%
183.72M
6.12%
276.56M
50.53%
593.62M
114.65%
832.99M
40.32%
878.36M
5.45%
258.52M
70.57%
-150.12M
158.07%
tangible book value per share
0.26
-
2.29
782.40%
4.92
114.46%
6.52
32.57%
5.36
17.76%
6.73
25.59%
12.76
89.62%
16.46
28.93%
16.04
2.55%
4.61
71.25%
-2.67
157.85%
working capital
800K
-
40.30M
4,937.63%
114.21M
183.39%
170.50M
49.29%
180.87M
6.08%
253.99M
40.43%
563.18M
121.73%
687.33M
22.04%
705.53M
2.65%
752.20M
6.61%
505.38M
32.81%

All numbers in USD (except ratios and percentages)